Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer (Q35528886)
Jump to navigation
Jump to search
scientific article published on 19 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer |
scientific article published on 19 July 2011 |
Statements
1 reference
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer (English)
1 reference
Stuart J Wong
1 reference
Kathryn Winter
1 reference
Neal J Meropol
1 reference
Pramila Rani Anne
1 reference
Lisa Kachnic
1 reference
Asif Rashid
1 reference
James C Watson
1 reference
Edith Mitchell
1 reference
Jondavid Pollock
1 reference
Robert Jeffrey Lee
1 reference
Michael Haddock
1 reference
Beth A Erickson
1 reference
Christopher G Willett
1 reference
19 July 2011
1 reference
82
1 reference
4
1 reference
1367-1375
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference